Hepatology News

After nearly a decade of health problems, Steve Harwell, former lead singer and frontman for the band Smash Mouth, died Sept. 4 at age 56, which the band’s manager, Robert Hayes, said was caused by acute liver failure.

ISA Pharmaceuticals announced that the first patient has been treated in its first-in-human phase 1 trial of its novel immunotherapeutic agent intended as a “functional cure” for patients with chronic hepatitis B virus infection.

As we discussed in our prior blog entry, you can expect that the buyer will require you to agree to non-compete restrictions.

As physicians age, they should consider the reallocation of their assets into increasingly conservative investments to best limit their exposure to loss.

Novo Nordisk has awarded a $9.57 million grant supporting a clinical trial at the University of California San Diego NAFLD Research Center to evaluate the use of semaglutide in patients with fibrosis due to nonalcoholic fatty liver disease.

The FDA expanded its approval of Gilead Sciences’ antiviral, Veklury, for the treatment of COVID-19 in patients with mild, moderate and severe hepatic impairment, without requiring dose adjustments, according to a manufacturer release.

Global burden of hepatitis B virus is estimated to be 257.5 million individuals, according to recent data in Lancet Gastroenterology & Hepatology, which, although lower than current WHO estimates, falls short of 2030 elimination targets.

As a wife, mother, community specialist and owner of an independent practice, I often am torn in millions of directions — and the pressure can be tremendous.

After you have decided to pursue a sale transaction, inevitably one of the biggest topics you’ll come across during the negotiation phase with the buyer is the non-compete restriction.

Researchers estimated that the introduction of generic medications for chronic hepatitis B virus infection could save Medicare Part D nearly $300 million annually from the cost of medication alone, according to data in Gastroenterology.